Bioanalytical Testing Services Market Size & Share, by Type (Cell-Based, In Vitro Virology, Biomarker, Pharmacokinetic, Serology); Molecule Type (Small Molecules, Large Molecules); Application (Cardiology, Gastroenterology, Neurology, Oncology); End-user (Pharmaceutical & Biopharmaceutical Institutions, Contract Research Organizations) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4227
  • Published Date: Feb 27, 2023
  • Report Format: PDF, PPT

Global Bioanalytical Testing Services Market Size, Forecast, and Trend Highlights Over 2023 - 2035

The global bioanalytical testing services market is estimated to garner a revenue of ~USD 11 Billion by the end of 2035 by growing at a CAGR of ~9% over the forecast period, i.e., 2023 – 2035. Further, the market generated a revenue of ~USD 4 Billion in the year 2022. To treat a wide range of disorders, the pharmaceutical and biotechnology industries are continually trying to produce novel treatments and cures. This raises the need for bioanalytical services since it necessitates extensive testing and analysis of biological materials. As of 2020, around 550 new medicines were found to be under development in the USA while nearly 50 novel drugs received approval from the Center for Drug Evaluation and Research (CDER).

The growth of the market is primarily ascribed to the escalating development of novel drugs and therapies, the rising outsourcing of R&D activities by pharmaceutical companies, and the rising number of innovations and new product developments. Many bioanalytical tests have seen major developments, allowing for a more precise and effective study of biological materials. As a result, test findings are more accurate and test costs are falling. Global bioanalytical testing services market trends such as the increasing number of clinical, pre-clinical, and laboratory testing services, advancement of biosimilars, and combination products are anticipated to influence the growth of the market positively over the forecast period. For instance, the annual rate of laboratory tests performed in the USA is estimated to be around 6 billion.

Get more information on this report: Request Free Sample PDF

Global Bioanalytical Testing Services Market: Growth Drivers and Challenges

Growth Drivers

  • Spiking Number of Medication Errors – The U.S. Food and Drug Administration stated to receive more than 100,000 medication errors annually. Medication error is a serious issue that occurs in the medical field, it is also estimated to cost someone his life. Henceforth, before making any new medical method, drug, therapy, and medicine available for the common people, proper research and testing are required. Such a demand for testing services is projected to hike the growth of the market over the forecast period.

  • Significant Growth in Blood Donation - The act of donating blood involves taking blood from a healthy person and using it to benefit others. Blood transfusion diagnostics and the maintenance of the blood supply depends on blood donation, and thus it needs to be properly assessed. As per the data provided by World Health Organization, it was stated that approximately 118.54 blood donations are collected worldwide and 40% of them come from developed countries.

  • Increasing Cases of Urinary Tract Infection (UTI) - There is a rising need for diagnosis, testing, and treatment of UTIs as the incidence of these illnesses rises. The fact that these services are utilized to identify UTIs is increasing the demand for bioanalytical testing services. As of 2019, It is observed that approximately 42% of women have UTIs and about 22% of them are above 65.

  • Higher Number of Ongoing Clinical Trials - Clinical trials are a crucial step in the development of novel medications and medical devices because they allow for the evaluation of their efficacy and safety. In mid-2021, around 425,000 studies were being conducted in about 220 countries.

  • Growing Healthcare Expenditure Across the Globe - The demand for bioanalytical testing services rises as a result of the increasing research on novel medications and treatments made possible by the increased expenditure. Based on the data provided by the World Bank, the healthcare expenditure of the world was stated to be 1,121.9 U.S. dollars per capita in 2019.


  • Lack of Skilled Medical Professionals - Bioanalytical testing requires skilled professionals to handle the equipment and the shortage of experienced people leads to the restraining of market growth.  The number of students who graduated every year was believed to be one-third of the vacancies available for the clinical laboratory science program. The low number is a limiting factor to using new technologies and methods in the bioanalytical testing service impeding market growth.
  • Requirement for Higher Initial Investment
  • Complex and Long-Lasting Procedure of Bioanalytical Testing

Global Bioanalytical Testing Services Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~ USD 4 Billion

Forecast Year Market Size (2035)

~ USD 11 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Global Bioanalytical Testing Services Market Segmentation

The global bioanalytical testing services market is segmented and analyzed for demand and supply by application into cardiology, gastroenterology, neurology, oncology, and others. Out of these, the cardiology segment is estimated to attain the largest share of the market over the forecast period. The growth of the segment can be accounted to the rising cases of cardiovascular diseases owing to unhealthy life choices, lack of exercise, and smoking habits. For instance, in 2020, approximately 600,000 people lost their lives in the United States as a result of cardiovascular disease.

Additionally, by molecule type, the market is segmented into small molecules and large molecules. Out of these, the small molecules segment has the largest market share in 2022, owing to its crucial role in creating generic versions of branded medications, the small molecule testing services sub-segment is predicted to experience growth. The effectiveness of simulating generic medication release profiles with those of branded drugs has been demonstrated through bioanalytical testing, which has contributed to the segment's expansion.

Our in-depth analysis of the global bioanalytical testing services market includes the following segments:

               By Type

  • Cell-Based
  • In Vitro Virology
  • Biomarker
  • Pharmacokinetic
  • Serology
  • Others

            By Molecule Type

  • Small Molecules – 57%
  • Large Molecules – 43%

          By Application

  • Cardiology
  • Gastroenterology
  • Neurology
  • Oncology
  • Others

            By End-User

  • Pharmaceutical & Biopharmaceutical Institutions
  • Contract Research Organizations

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Global Bioanalytical Testing Services Market Regional Synopsis

The North American region bioanalytical testing services market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2035. The growth of the market in the region is ascribed to the mounting investment in the R&D expenditure in the pharmaceutical industry. For instance, in 2019, the investment made by significant key players was valued at around USD 100 billion. Additionally, growing chronic diseases and the presence of well-developed healthcare infrastructure in the region are further anticipated to influence the growth of the market over the forecast period. For instance, 5 out of 10 adults in the USA have some sort of chronic disease. Chronic diseases such as stroke, cancer, heart disease, and diabetes are more prevalent in the region. All these factors are estimated to foster the growth of the market over the forecast period.

Additionally, the market in the Europe region is also projected to grow rapidly over the forecast period on the back of the increase in funding for pharmaceutical and biotechnology R&D operations. Also, the market in Europe is being driven by the rise in cardiovascular disease. For instance, 3.9 million fatalities in Europe were attributed to cardiovascular disease in 2017. High blood sugar contributes to 15% of cardiovascular fatalities in the area. Diabetes is very common in this area. In the past ten years, it has grown quickly, rising by more than 50% in a number of the region's countries. Hence, all these factors are estimated to hike the market growth over the forecast period.

Research Nester
Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Global Bioanalytical Testing Services Market

    • Charles River Laboratories, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Vipragen Biosciences Private Limited
    • Medpace Holdings, Inc.
    • Pace Analytical Services, LLC
    • WuXiAppTec Co., Ltd.
    • Eurofins Scientific SE
    • Intertek Group plc
    • SGS S.A.
    • Almac Group
    • BioAgilytix Labs


In The News

  • Pace Analytical Services, LLC to receive approval for its Pace, a method to detect dibenzofurans and dioxins with the assistance of technology called GCMS/MS.

  • Medpace Holdings, Inc. to elaborate on avoiding basic pitfalls in clinical trials associated with cell therapy. The experts of Medpace Holdings, Inc. bring light to strategies and challenges by including various range of topics such as the capacity of clinical trials, managing complex logistics, regulatory strategy, and others.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 4227
  • Published Date: Feb 27, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Escalating development of novel drugs and therapies, significant growth in blood donation, and spiking number of medication errors are some major factors driving the growth of the market.

The market is anticipated to attain a CAGR of ~9% over the forecast period, i.e., 2023 – 2035.

Requirement for higher initial investment, complex and long-lasting procedure of bioanalytical testing, and lack of skilled medical professional are the challenges affecting the market growth.

The market in North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Vipragen Biosciences Private Limited, Medpace Holdings, Inc., Pace Analytical Services, LLC, WuXiAppTec Co., Ltd., Eurofins Scientific SE, Intertek Group plc, SGS S.A., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, molecule type, application, end-user, and by region.

The small molecules segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Bioanalytical Testing Services Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying